ArticleFunctional & integrative genomics2025
Genomic insights into the antagonistic activity of Paenibacillus brasilensis PB24 against Fusarium oxysporum: implications for biocontrol and plant growth promotion strategies.
Article in Functional & integrative genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Biocontrol to Synthesis: Innovative Progress ofInternational journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biotechnology and sustainable strategies are the way forward for increasing global food production. The use of plant growth-promoting bacteria to increase the productivity of important food crops helps reduce the need for land expansion, improves soil fertility and plant tolerance to adverse abiotic conditions, and increases the ability to combat phytopathogens. Paenibacillus brasilensis strain PB24 is an endospore-forming bacterium that promotes plant growth through various direct and indirect mechanisms. To improve the understanding of its ability to inhibit the fungus Fusarium oxysporum, which causes numerous agricultural pathologies, the potential of P. brasilensis PB24 as a producer of antifungal compounds was investigated. In vitro assays demonstrated fungicidal activity against F. oxysporum hyphae. Additionally, genome mining of P. brasilensis PB24 was conducted to identify biocontrol and plant growth-promoting traits. For the first time, these traits were compared with those of other Paenibacillus species, and several genetic similarities were identified. Genome mining revealed that strain PB24 produces several antimicrobial compounds, similar to fusaricidin and sevadicin, but retains substantial differences in their monomers, suggesting that they may be novel lipopeptides. A unique genetic cluster was characterized in the PB24 genome as a potential resource for the discovery of new compounds. The results demonstrate the biotechnological potential of P. brasilensis PB24 for plant growth and biocontrol of phytopathogens and provide a basis for the future development of sustainable biocontrol strategies and commercial bacterial formulations.
Indexed as
Identifiers
40866670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.